Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 226.42 -2.82% -6.56
MDGL closed up 0.7 percent on Tuesday, April 16, 2024, on 53 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 7
*** please verify all earnings dates ***
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Gapped Down Weakness -2.82%
Lower Bollinger Band Touch Weakness -2.82%
Oversold Stochastic Weakness -2.82%
50 DMA Resistance Bearish -2.14%
Expansion Pivot Sell Setup Bearish Swing Setup -2.14%
Oversold Stochastic Weakness -2.14%
Fell Below 50 DMA Bearish -4.30%
Stochastic Reached Oversold Weakness -4.30%
Oversold Stochastic Weakness -4.30%
MACD Bearish Centerline Cross Bearish -7.69%

   Recent Intraday Alerts

Alert Time
Down 3% 15 minutes ago
60 Minute Opening Range Breakdown 27 minutes ago
Down 2 % 27 minutes ago
Fell Below Lower Bollinger Band about 1 hour ago
Down 1% about 1 hour ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medication Lipid Endocrine System Metabolic Disease Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Cardiovascular And Metabolic Diseases Hyperlipidemia Vascular And Metabolic Diseases

Is MDGL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 322.67
52 Week Low 119.7604
Average Volume 645,376
200-Day Moving Average 202.02
50-Day Moving Average 241.00
20-Day Moving Average 248.40
10-Day Moving Average 241.86
Average True Range 12.85
RSI (14) 42.20
ADX 10.52
+DI 17.27
-DI 26.59
Chandelier Exit (Long, 3 ATRs) 261.43
Chandelier Exit (Short, 3 ATRs) 261.45
Upper Bollinger Bands 267.18
Lower Bollinger Band 229.63
Percent B (%b) 0.09
BandWidth 15.12
MACD Line -3.06
MACD Signal Line -0.25
MACD Histogram -2.8049
Fundamentals Value
Market Cap 4.6 Billion
Num Shares 19.7 Million
EPS -19.24
Price-to-Earnings (P/E) Ratio -12.11
Price-to-Sales 0.00
Price-to-Book 168.57
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 252.51
Resistance 3 (R3) 251.32 243.62 249.26
Resistance 2 (R2) 243.62 238.65 244.22 248.17
Resistance 1 (R1) 238.30 235.57 240.96 239.49 247.08
Pivot Point 230.60 230.60 231.93 231.20 230.60
Support 1 (S1) 225.28 225.63 227.94 226.47 218.88
Support 2 (S2) 217.58 222.55 218.18 217.79
Support 3 (S3) 212.26 217.58 216.71
Support 4 (S4) 213.45